Parrish Capital
GSK icon

Parrish Capital’s GSK GSK Stock Holding History

Parrish Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.49M Buy
30,927
+1,317
+4% +$67.2K 1.45% 21
2026
Q2 		$1.55M Buy
29,610
+22
+0.1% +$1.16K 1.5% 19
2026
Q1 		$1.63M Sell
29,588
-639
-2% -$34.6K 1.46% 25
2025
Q4 		$1.48M Buy
+30,227
New +$1.41M 1.34% 28

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Parrish Capital's GSK Position: Q3 2026 in Review

Parrish Capital increased its GSK (GSK) stake by 4.4% in Q3 2026, buying an estimated $67.2K and bringing the position to 30,927 shares worth $1.49M. The position accounts for 1.45% of the portfolio, ranked #21.

Parrish Capital first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.63M in Q1 2026. 402 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Parrish Capital held 30,927 shares of GSK worth $1.49M as of Q3 2026.
  • Parrish Capital bought 1,317 GSK shares in Q3 2026, an estimated $67.2K.
  • GSK made up 1.45% of Parrish Capital's portfolio in Q3 2026, its #21 holding.
  • Parrish Capital first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Parrish Capital's GSK position peaked at $1.63M in Q1 2026.
  • 402 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.